Skip to main content

Research Repository

Advanced Search

Prescriptions of Essentially Placebo Treatments Among General Practitioners in 21 Countries.

Wolters, Fabian; Peerdeman, Kaya; Gussekloo, Jacobijn; Adler, Limor; Asenova, Radost; Kánská, Petra Bomberová; Collins, Claire; Dumitra, Gheorghe Gindrovel; Howick, Jeremy; Peštić, Sanda Kreitmayer; Kurpas, Donata; Lazic, Vanja; Lingner, Heidrun; Mallen, Christian D.; Missiou, Aristea; Peremans, Lieve; Petrazzuoli, Ferdinando; Pilv-Toom, Liina; Poortvliet, Rosalinde K.E.; Thulesius, Hans O.; Torzsa, Péter; Tsopra, Rosy; Tkachenko, Victoria; Viegas, Rita; Evers, Andrea W. M.; Streit, Sven

Authors

Fabian Wolters

Kaya Peerdeman

Jacobijn Gussekloo

Limor Adler

Radost Asenova

Petra Bomberová Kánská

Claire Collins

Gheorghe Gindrovel Dumitra

Jeremy Howick

Sanda Kreitmayer Peštić

Donata Kurpas

Vanja Lazic

Heidrun Lingner

Aristea Missiou

Lieve Peremans

Ferdinando Petrazzuoli

Liina Pilv-Toom

Rosalinde K.E. Poortvliet

Hans O. Thulesius

Péter Torzsa

Rosy Tsopra

Victoria Tkachenko

Rita Viegas

Andrea W. M. Evers

Sven Streit



Abstract

General practitioners (GPs) sometimes initiate a treatment despite not expecting it to improve patients' symptoms by any physiological mechanism. These essentially placebo treatments are ethically controversial, and their frequency is unclear. They involve risks for patients, but to estimate these, more data are needed. To develop a more precise overview of the rate at which GPs prescribe essentially placebo treatments. This cross-sectional survey study included currently practicing GPs from 20 European countries and Israel who responded to online questionnaires. The online questionnaires were taken between December 12, 2019, and August 4, 2021, and analyzed on April 28, 2022. Respondents were contacted by national representatives, either through personal networks (convenience sampling) or an existing database (volunteer sampling). The main outcome was the rate of essentially placebo prescriptions, given as the rate per week and the proportion of consultations. Secondary outcomes were the associations between this rate and GP background characteristics (gender, age, education about placebos, years of experience, patients seen, and working hours per week). A total of 952 practicing GPs responded (453 of 745 [61%] female; mean [SD] age of 48.02 [11.95] years), and 669 answered all questions. Overall, 689 of 818 respondents (84%) indicated they had prescribed an essentially placebo treatment at least once. Overall, the median (IQR) rate of essentially placebo prescriptions was 0.5 (0.1 to 2.0) per week or 0.67% (0.06% to 2.50%) of consultations. The prescription rate was higher in men (β = 1.94 [95% CI, 0.58 to 3.29]; P = .005), those with more work experience (β = 0.12 [95% CI, 0.06 to 0.18]; P < .001), and those who work fewer hours per week (β = -0.08 [95% CI, -0.13 to -0.03]; P = .001). In this survey study of GPs across 21 countries, essentially placebo prescriptions featured in a small minority of consultations, but they nevertheless occurred regularly for most GPs. Rates varied only slightly by GP background characteristics. This suggests that essentially placebo prescriptions were common at a population level, which poses risks for the patient-GP relationship and creates medical risks for patients. Future research should further investigate the decision-making process behind these prescriptions and their effects on patients.

Citation

Wolters, F., Peerdeman, K., Gussekloo, J., Adler, L., Asenova, R., Kánská, P. B., Collins, C., Dumitra, G. G., Howick, J., Peštić, S. K., Kurpas, D., Lazic, V., Lingner, H., Mallen, C. D., Missiou, A., Peremans, L., Petrazzuoli, F., Pilv-Toom, L., Poortvliet, R. K. E., …Streit, S. (2025). Prescriptions of Essentially Placebo Treatments Among General Practitioners in 21 Countries. Jama Network Open, 8(9), 1-10, e2532672. https://doi.org/10.1001/jamanetworkopen.2025.32672

Journal Article Type Article
Acceptance Date Jul 3, 2025
Online Publication Date Sep 18, 2025
Publication Date 2025-09
Deposit Date Oct 9, 2025
Journal JAMA network open
Print ISSN 2574-3805
Electronic ISSN 2574-3805
Publisher American Medical Association
Peer Reviewed Peer Reviewed
Volume 8
Issue 9
Article Number e2532672
Pages 1-10
DOI https://doi.org/10.1001/jamanetworkopen.2025.32672
Keywords Cross-Sectional Studies, Middle Aged, Practice Patterns, Physicians' - statistics & numerical data, Europe, General Practitioners - statistics & numerical data, Adult, Placebos - therapeutic use, Surveys and Questionnaires, Israel, Female, Male, Humans
Public URL https://keele-repository.worktribe.com/output/1449679